Veritas Life Sciences

Accelerating Biotechnological Development

What we do

We carry out research and development of new molecules for human health, with patents granted in Brazil and the USA for a new monoclone antibodyl for cancer treatment.
We make our biotech platform and team expertise available to help other companies move forward. Our platform includes state-of-the-art technologies to solve all of the country's needs and challenges in protein analysis.

Markets

Find out which markets Veritas Life Sciences operates in

Services

Find out which services Veritas Life Sciences performs

General about Services

Our mission is to help the scientific community, public or private, to address/solve all their needs in protein analysis

Proteomic Analysis

We are the first Brazilian company to provide proteomic analysis services. We use of state-of-the-art equipment to provide our solutions

Biomarkers Identification

We perform discovery and validation of proteomic biomarkers. We also carry out with a partner in the USA, analyzes of toxicity in animal models

Proteins Identification

We perform protein extraction, purification and complete characterization including the identification of proteins

N-Terminal

N-terminal sequencing of a protein is performed by the chemical technique of Edman's Automated Degradation. 283–293

Consulting

Veritas provides strategic consulting and training in biotechnology, biomarker identification, proteomic analysis, bioinformatics, protein purification

Research and Development

Learn about the Research, Development and Innovation that Veritas works with its partners

Monoclonal Antibodies for Cancer

New Antibacterial Agents

Platform and Strategy

Our Differentials

High tech

State-of-the-art technologies and reference in advanced protein analysis

International quality

US partners for access to state-of-the-art technologies and consulting

Brazilian company

Guarantee of fast delivery of results

Our Clients and Partners

Veritas' main customers are pharmaceutical, cosmetics, biotechnology, agribusiness companies, and research institutes and researchers from public or private universities.
We have partners in the USA for access to technologies and market consulting.